BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8452114)

  • 21. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
    Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
    J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial.
    Malik IA; Khan WA; Qazilbash M; Ata E; Butt A; Khan MA
    Am J Clin Oncol; 1995 Apr; 18(2):170-5. PubMed ID: 7900711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The prevention of CDDP-induced emesis with a combination regimen including metoclopramide, dexamethasone, droperidol and diphenhydramine].
    Dozono H; Yasuda M; Yokoyama S; Takahashi S; Ochiai K; Tsuruoka M; Morimoto O; Sasaki H; Arihiro T; Terashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):1968-72. PubMed ID: 3429979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial for the control of acute vomiting in cisplatin-treated patients: high-dose metoclopramide with dexamethasone and lorazepam as adjuncts versus high-dose alizapride plus dexamethasone and lorazepam. Study of the incidence of delayed emesis.
    Moreno I; Rosell R; Abad-Esteve A; Barnadas A; Carles J; Ribelles N
    Oncology; 1991; 48(5):397-402. PubMed ID: 1745488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis.
    Kris MG; Tyson LB; Clark RA; Gralla RJ
    Cancer; 1992 Aug; 70(4 Suppl):1012-6. PubMed ID: 1386282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis.
    Gordon CJ; Pazdur R; Ziccarelli A; Cummings G; Al-Sarraf M
    Cancer; 1989 Feb; 63(3):578-82. PubMed ID: 2912533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.
    Roila F
    Oncology; 1993; 50(3):163-7. PubMed ID: 8459986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Research on antiemetics: an Italian model of success].
    Roila F
    Tumori; 1998; 84(1 Suppl):S3-11. PubMed ID: 9617377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis.
    Mori K; Saito Y; Tominaga K
    Am J Clin Oncol; 1993 Aug; 16(4):338-41. PubMed ID: 8392288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patients.
    Roila F; Basurto C; Bracarda S; Picciafuoco M; Ballatori E; Del Favero A; Tonato M
    Oncology; 1990; 47(5):415-7. PubMed ID: 2216296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose ondansetron and dexamethasone: a cost effective alternative to high dose metoclopramide/dexamethasone/lorazepam in the prevention of acute cisplatin induced emesis.
    Sands R; Roberts JT; Marsh M; Gill A
    Clin Oncol (R Coll Radiol); 1992 Jan; 4(1):67. PubMed ID: 1531293
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
    Gebbia V; Testa A; Valenza R; Cannata G; Tirrito ML; Gebbia N
    Cancer; 1995 Nov; 76(10):1821-8. PubMed ID: 8625054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis.
    Roila F; Basurto C; Bracarda S; Sassi M; Lupattelli M; Picciafuoco M; Boschetti E; Tonato M; Del Favero A
    Eur J Cancer; 1991; 27(2):119-21. PubMed ID: 1827271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of intravenous granisetron with metoclopramide in the treatment of chemotherapy-induced emesis.
    Chiou TJ; Wei CH; Hsieh RK; Fan FS; Liu JH; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jul; 56(1):23-30. PubMed ID: 7553406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin.
    Cleri LB; Kris MG; Tyson LB; Pisters KM; Clark RA; Gralla RJ
    Cancer; 1995 Sep; 76(5):774-8. PubMed ID: 8625179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
    Fanning J; Hilgers RD
    Obstet Gynecol; 1994 Apr; 83(4):601-4. PubMed ID: 8134073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of intermittent versus continuous infusion metoclopramide in control of acute nausea induced by cisplatin chemotherapy.
    Navari RM
    J Clin Oncol; 1989 Jul; 7(7):943-6. PubMed ID: 2544688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial.
    Warr D; Wilan A; Venner P; Pater J; Kaizer L; Laberge F; Latreille J; Stewart D; O'Connell G; Osoba D
    Eur J Cancer; 1992; 29A(1):33-6. PubMed ID: 1332737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diphenhydramine for nausea and vomiting related to cancer chemotherapy with cisplatin.
    Tsavaris N; Zamanis N; Zinelis A; Tsoutsos E; Mylonakis N; Bacoyannis C; Valilis P; Sarafidou M; Kosmidis P
    J Pain Symptom Manage; 1991 Nov; 6(8):461-5. PubMed ID: 1955741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin.
    Mantovani G; Macciò A; Curreli L; Lampis B; Ghiani M; Bianchi A; Contu P
    Oncol Rep; 1998; 5(1):273-80. PubMed ID: 9458381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.